Literature DB >> 7631603

Effect of beta-adrenergic receptor blockade on the physiologic response to dobutamine stress echocardiography.

N J Weissman1, M W Levangie, J B Newell, J L Guerrero, A E Weyman, M H Picard.   

Abstract

Dobutamine is an effective pharmacologic stress agent because of its beta-adrenergic receptor agonist properties. Theoretically, concurrent beta-adrenergic receptor blockade might alter this effectiveness, but clinical experience has been variable. Before assessing the relative effectiveness and implications of dobutamine stress echocardiography (DSE) to detect myocardial ischemia in the presence of beta-blockade the physiologic and hemodynamic effects of dobutamine with simultaneous beta-blockade must be understood in a controlled setting. Therefore the purpose of this study was to determine if beta-blocking agents alter the timing and magnitude of the physiologic response to graded doses of dobutamine during a standard DSE. Paired DSEs were performed in seven instrumented open-chest dogs with and without beta-blockade (esmolol 500 micrograms/kg initial bolus and 100 micrograms/kg/min infusion). Heart rate, systolic pressure, proximal left anterior descending coronary artery flow, myocardial thickening, and percentage left ventricular area change (% AC) were monitored. The data for each parameter were fit to linear or exponential functions. With graded doses of dobutamine, the rate of increase in coronary flow was greater than that in %AC, which in turn was greater than that in heart rate (p < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7631603     DOI: 10.1016/0002-8703(95)90436-0

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

Review 1.  beta-blockers. Drug interactions of clinical significance.

Authors:  I Blaufarb; T M Pfeifer; W H Frishman
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

2.  Dobutamine stress echocardiography for the detection of myocardial viability in patients with left ventricular dysfunction taking beta blockers: accuracy and optimal dose.

Authors:  T Zaglavara; R Haaverstad; B Cumberledge; T Irvine; H Karvounis; G Parharidis; G Louridas; A Kenny
Journal:  Heart       Date:  2002-04       Impact factor: 5.994

3.  Very-low-dose continuous drip infusion of landiolol hydrochloride for postoperative atrial tachyarrhythmia in patients with poor left ventricular function.

Authors:  Akimasa Morisaki; Mitsuharu Hosono; Yasuyuki Sasaki; Hidekazu Hirai; Masanori Sakaguchi; Atsushi Nakahira; Hiroyuki Seo; Shigefumi Suehiro
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-05-08

4.  Clinical assessment of myocardial viability using MRI during a constant infusion of Gd-DTPA.

Authors:  R S Pereira; G Wisenberg; F S Prato; K Yvorchuk
Journal:  MAGMA       Date:  2000-12       Impact factor: 2.533

5.  The effects of beta-blockers on dobutamine-atropine stress echocardiography: early protocol versus standard protocol.

Authors:  Ana C Camarozano; Plínio Resende; Aristarco G Siqueira-Filho; Luis H Weitzel; Rosangela Noe
Journal:  Cardiovasc Ultrasound       Date:  2006-07-19       Impact factor: 2.062

6.  Early and long-term outcome of elective stenting of the infarct-related artery in patients with viability in the infarct-area: Rationale and design of the Viability-guided Angioplasty after acute Myocardial Infarction-trial (The VIAMI-trial).

Authors:  Ramon B van Loon; Gerrit Veen; Otto Kamp; Jean Gf Bronzwaer; Cees A Visser; Frans C Visser
Journal:  Curr Control Trials Cardiovasc Med       Date:  2004-11-11

7.  Quality Assessment in Dobutamine Stress Echocardiography: What are the Clinical Predictors Associated With a Non-Diagnostic Test?

Authors:  Katie M Hawthorne; Amer M Johri; Rajeev Malhotra; Judy Hung; Aaron Baggish; Michael H Picard
Journal:  Cardiol Res       Date:  2012-03-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.